Detalhe da pesquisa
1.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Blood
; 141(8): 917-929, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356299
2.
Evaluation of the ATM L2307F germline variant in 121 Italian pedigrees with familial myeloproliferative neoplasms.
Haematologica
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654656
3.
Novel drivers and modifiers of MPL-dependent oncogenic transformation identified by deep mutational scanning.
Blood
; 135(4): 287-292, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697803
4.
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms.
Blood
; 135(2): 133-144, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697806
5.
Primary Budd-Chiari Syndrome.
N Engl J Med
; 389(8): 769, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37611130
6.
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.
Blood
; 134(2): 199-210, 2019 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31064751
7.
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
Hematol Oncol
; 38(4): 554-559, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583904
8.
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance.
Int J Mol Sci
; 21(23)2020 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33255170
9.
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.
Blood
; 129(24): 3227-3236, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351937
10.
Clinical significance of somatic mutation in unexplained blood cytopenia.
Blood
; 129(25): 3371-3378, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424163
11.
Autoantibodies against type I IFNs in patients with Ph-negative myeloproliferative neoplasms.
Blood
; 139(17): 2716-2720, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100354
12.
Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.
Blood
; 127(3): 325-32, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26423830
13.
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts.
Blood
; 126(2): 233-41, 2015 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25957392
14.
Isolated congenital asplenia: An overlooked cause of thrombocytosis.
Am J Hematol
; 97(8): 1110-1115, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35266186
15.
Sequential next generation sequencing analysis in homogeneously treated low risk NPM1-mutated acute myeloid leukemia with an adverse clinical outcome.
Am J Hematol
; 97(4): E135-E138, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041232
16.
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis.
Int J Cancer
; 138(7): 1657-69, 2016 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26547506
17.
Somatic mutations of calreticulin in myeloproliferative neoplasms.
N Engl J Med
; 369(25): 2379-90, 2013 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24325356
18.
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.
Blood
; 123(15): 2416-9, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24553179
19.
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis.
Blood
; 124(13): e21-32, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25097177
20.
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Blood
; 123(10): 1544-51, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24366362